– Information sur les médicaments Swissmedic
(
www.swissmedicinfo.ch)
– Micromedex® 2.0, (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at:
http://www.micromedexsolutions.com/ (cited: 01/01/2017).
– DHPC – Méthotrexate à faible dose en cas de polyarthrite rhumatoïde et de psoriasis.
https://www.swissmedic.ch/marktueberwachung/00135/00157/03478/index.html?lang=fr
– Weinblatt ME, Dixon JA, Falchuk KR. Serious liver disease in a patient receiving methotrexate and leflunomide. Arthritis Rheum. 2000;43:2609–11.
– Frenia ML, Long KS. Methotrexate and nonsteroidal anti-inflammatory drug interaction. Ann Pharmacother. 1992;26:234–7.
– Cassano W. Serious methotrexate toxicity caused by interaction with ibuprofen. Am J Ped Hematol/Oncol. 1989;11:481–2.
– Thyss A, Milano G, Kubar J, Namer M, Schneider M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet. 1986;1(8475):256–8.
– Singh RR, Malaviya AN, Pandey JN, Guleria JS. Fatal interaction between methotrexate and naproxen. Lancet. 1986;1(8494):1390.
– Adams JD, Hunter G. Drug interaction in psoriasis.
Aust J Dermatol. 1976;17:39.
– Mayall B, Poggi G, Parkin JD. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatal. Med J Aust. 1991;155:480–4.
– Santucci R , Leveque D , Kemmel V , et al: Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors. Anticancer Res. 2010;30:963–5.
– Troger U, Stotzel B, Martens-Lobenhoffer J, et al: Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate. BMJ. 2002;324:1497.
– Karlen S, Oertle M, Weiler S, Schneemann M, Eschmann E, Kullak-Ublick GA, Blaser J. Too frequent low-dose methotrexate prescriptions: multicentre quality control and quality assurance with pre- and post-analysis. Swiss Med Wkly. 2015;145:w14218.